Top line accelerating.
+5.2% YoY versus +2.0% prior. 3y CAGR +3.3%.
+5.2%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $8.5B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
Concerns — Bio-Techne Corporation's 5.3% ROE is below sector median.
Financial story
Concerns — Bio-Techne Corporation's 5.3% ROE and 0.22 debt-to-equity warrant a closer look at the underlying business.
Bottom line: TECH currently has no legendary investor models qualifying — see /stock/TECH/valuation for the per-model breakdown, but earns a D sector grade (40/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
+5.2% YoY versus +2.0% prior. 3y CAGR +3.3%.
+5.2%Net margin 6.0% versus 14.5% prior (−8.5pp). Operating 8.4%.
6.0%P/E 75.3x — 15% above the 5y median of 65.3x. Forward 26.9x hints at EPS expansion next year.
75.3xThe Question
How does TECH compare?
TECH's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
TECH is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate TECH a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Bio-Techne Corporation's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
TECH trades at 70.1x earnings. Sector context and per-investor signals are in the valuation tab.
TECH and QGEN differ on P/E, ROE, and revenue growth. See the full TECH vs QGEN compare matrix.
See exactly where TECH ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingTECH sits at #93 in Healthcare with a D grade (40/100).